Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 84 of 46062 for:    intensity

High-Intensity-Interval-Training in Geriatric Rehabilitation - A Feasibility Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04025385
Recruitment Status : Recruiting
First Posted : July 18, 2019
Last Update Posted : August 22, 2019
Sponsor:
Information provided by (Responsible Party):
Michael Kruesi, Klinik Valens

Brief Summary:
Study with Patients (40-60 participants) above the age of 65. There will be a comparison of regular training on ergometer (10 trainings within 2 weeks, 40 min each) to high intensity interval training on ergometer (6 trainings within 2 weeks, 25 min each). At the beginning and at the end will be a spiroergometer to measure the individual limits and vO2max, which will be compared amongst the two groups. To receive a subjective feedback, there will be a series of questionnaires at the beginning, after one week and at the end. The goal of this study is to get more information about whether a HII-Training is feasible with elderly patients and whether they can profit form it.

Condition or disease Intervention/treatment Phase
Rehabilitation Post-Operative Condition Deconditioning After Acute Hospital Oncology Other: High Intensity Interval Training Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: High-Intensity-Interval-Training in Geriatric Rehabilitation - A Feasibility Study
Actual Study Start Date : July 30, 2019
Estimated Primary Completion Date : September 30, 2019
Estimated Study Completion Date : December 15, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Rehabilitation

Arm Intervention/treatment
No Intervention: Control Group
Patients will participate in regular training units
Active Comparator: HIIT Group
Patients will participate in high intensity interval training
Other: High Intensity Interval Training
Training for 25 min with four 1 minute intervals when participants exercise up to 80% of their individual limits.




Primary Outcome Measures :
  1. Will there be a change in outcome of individuals vO2max? [ Time Frame: 2 Weeks ]
    Measurement of vO2max with spiroergometer at the beginning and end

  2. Is a High intensity interval training feasible with elderly patients in rehabilitation? [ Time Frame: 1 Day ]
    Questionnaire (Clinic-intern questionnaire) amongst the involved personal


Secondary Outcome Measures :
  1. Will there be a change in subjective quality of life? [ Time Frame: 2.5 Weeks ]
    Questionnaires (PROMIS-10, EQ-5D) amongst the participants



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • cardiopulmonal resilient
  • able to sit on a ergometer
  • knowledge of German written and spoken

Exclusion Criteria:

  • Severe cardiopulmonary restriction (LVEF <30%, conduction abnormalities from AV block IIb or higher)
  • Absolute cardiopulmonary contraindications (acute coronary syndrome, unstable AP -> not capable of rehabilitation), uncompensated heart failure (dyspnea at rest, orthopnea, severe edema)
  • No ischemic events (cardiac, cerebral, peripheral) within the last 3 months
  • Severe pneumatological underlying disease: COPD GOLD 3 and higher or status after exacerbation within the last 2 weeks, Asthma grade 4
  • Dyalisis reliant
  • Severe psychiatric disorder (severe psychosis, severe depression)
  • Distinct dementia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04025385


Locations
Layout table for location information
Switzerland
Rehazentrum Walenstadtberg Recruiting
Walenstadtberg, Switzerland
Contact: Stefan Bachmann, Prof.    0041813031412    stefan.bachmann@kliniken-valens.ch   
Sponsors and Collaborators
Klinik Valens

Layout table for additonal information
Responsible Party: Michael Kruesi, Resident Physician, Doctoral Candidate, Klinik Valens
ClinicalTrials.gov Identifier: NCT04025385     History of Changes
Other Study ID Numbers: KLV-BA-2019-1
First Posted: July 18, 2019    Key Record Dates
Last Update Posted: August 22, 2019
Last Verified: August 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Neoplasms